Eve & Co. Announces Medical Cannabis Supply & Purchase Agreement With Cannamedical Pharma GmbH

Published: July 26, 2021

Eve & Co. Announces Medical Cannabis Supply & Purchase Agreement With Cannamedical Pharma GmbH

Eve & Co Incorporated announce that its wholly-owned subsidiary, Natural MedCo Ltd. (NMC) has successfully entered into a Medical Cannabis Supply and Purchase Agreement with Cannamedical Pharma® GmbH (CM), an import / export and distribution company of para-pharmaceutical, medicinal and narcotic products headquartered in Cologne, Germany. Pursuant to the Agreement, NMC will export medical graded dried cannabis flower to CM and CM will distribute medical graded cannabis products in Germany. CM specializes in the import and distribution of medicinal cannabis to pharmacies and clinical facilities in the European Union (the “EU”).

“We are very pleased to be able to work with one of the leading medical cannabis wholesalers in the EU for the potential supply of up to approximately $7M of cannabis product over the next two years. CM is committed to improving patients’ quality of life, and as this parallels our directive, we are pleased to assist CM in this goal. This agreement is one of the ten supply agreements we have with buyers in Germany and forms part of our strategy to provide significant supply in the EU,” commented Melinda Rombouts, President and Chief Executive Officer at Eve & Co.

ABOUT EVE & CO.
Eve & Co, through its wholly owned subsidiary Natural MedCo Ltd., holds cultivation and processing licenses under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and extraction of cannabis oil and has received EU GMP certification. The Company’s website can be visited at www.evecannabis.ca